Eton Pharmaceuticals (ETON) Assets Average (2018 - 2025)

Eton Pharmaceuticals has disclosed Assets Average across 8 years of filings, most recently posting $98.3 million for Q4 2025.

• Assets Average for Q4 2025 came in at $98.3 million, up 75.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $98.3 million (up 75.61% YoY), and the FY2025 annual result was $84.1 million, up 55.97% from the prior year.
• Assets Average came in at $98.3 million for Q4 2025 at Eton Pharmaceuticals, down from $103.1 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $103.1 million in Q3 2025 to a low of $22.3 million in Q3 2022.
• The 5-year median for Assets Average is $30.9 million (2021), against an average of $42.5 million.
• Across the five-year window, Assets Average slipped 24.31% in 2022 and soared 204.72% in 2025, its largest moves.
• Eton Pharmaceuticals' Assets Average stood at $27.0 million in 2021, then slipped by 13.91% to $23.3 million in 2022, then surged by 35.91% to $31.6 million in 2023, then jumped by 76.97% to $56.0 million in 2024, then jumped by 75.61% to $98.3 million in 2025.
• The last three Assets Average figures came in at $98.3 million (Q4 2025), $103.1 million (Q3 2025), and $92.9 million (Q2 2025), per Business Quant data.